버닝락 바이오테크 (BNR) 주가

버닝락 바이오테크(BNR)는 NASDAQ에 상장된 Healthcare · Diagnostics & Research 기업입니다. 현재가 $14.23 (+5.29%), 시가총액 $0.18B, 52주 최저~최고 $2.72 ~ $41.06.

Burning Rock Biotech Limited develops and sells cancer therapy selection tests in the People's Republic of China and the United States. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company offers next-generation sequencing (NGS)-based tissue, liquid biopsy cancer therapy selection, and prognosis prediction tests for various cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its key products include OncoScreen Focus, a multi-ge

핵심 지표

• 현재가: $14.23 (+5.29%)
• 시가총액: $0.18B
• 52주 최저~최고: $2.72 ~ $41.06
• 섹터: Healthcare
• 산업: Diagnostics & Research
• 거래소: NASDAQ

버닝락 바이오테크의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

버닝락 바이오테크 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 5

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 2.26
• 순이익률: -0.10%
• 영업이익률: -0.10%

자주 묻는 질문